FocusInfectious Disease

Neutralizing the MERS Coronavirus Threat

See allHide authors and affiliations

Science Translational Medicine  07 May 2014:
Vol. 6, Issue 235, pp. 235fs19
DOI: 10.1126/scitranslmed.3009132

You are currently viewing the abstract.

View Full Text

Abstract

Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

View Full Text